Skip to content

Study · Observational study · n = 24 · 1989

1 result

Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.

Feldberg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Dicker D, Goldman JA

Fertility and sterility1 Jan 1989Cited by 34 (Europe PMC)

PMID2521325 (opens in a new tab)DOI10.1016/s0015-0282(16)60425-9 (opens in a new tab)PepBankPUB-02521325
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanObservational studySafety outcome

    During Decapeptyl down-regulation for IVF-ET, solitary ovarian cysts developed in 7 of 24 patients.

    In plain wordsDuring Decapeptyl treatment for IVF, ovarian cysts developed in 7 of 24 patients.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    Not applicableOvarian cyst formation
    Study

    n = 24

    Outcome group
    Adverse events · Reproductive and sexual health
    Studied dose
    Dose not stated

    Measurements

    Patients with ovarian cysts
    7 patients
    Decapeptyl

    Source sentences

    Summary
    In 7 of 24 patients with Decapeptyl (D-Trp6-luteinizing hormone-releasing hormone [LH-RH], Ferring, Kiel, FRG) treatment,
    2 context sentences
    Summary · context
    solitary ovarian cysts developed during the down-regulation phase.
    Summary · context
    The authors have encountered a rather infrequent complication, namely ovarian cystic formations, when using these compounds for selected in vitro fertilization and embryo transfer (IVF-ET) cases.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.